News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Aakash Desai/LinkedIn
Jan 9, 2025, 16:29

Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib

Aakash Desai, Assistant Professor at UAB O’Neal Comprehensive Cancer Center, shared on X:

“MARIPOSA Johnson and Johnson announces Positive OS results in 1L EGFR

Amivantamab + lazertinib vs. osimertinib:
Statistically significant improvement in OS (press release states >1 yr survival benefit)
Await complete data and presentation.”

Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib

 

Aakash Desai cancer EGFR Lung cancer OncoDaily Oncology
Special Coverage
Blog
Jan 9, 2025, 16:29
Aakash Desai: Rybrevant + Lazcluze to show clinically meaningful improvement in OS vs osimertinib
Blog
Jan 9, 2025, 16:22
Isabel Preeshagul: Survey on addressing barriers to clinical trial accrual in patients with lung cancer
Blog
Jan 9, 2025, 16:20
Saddened to learn of the unexpected passing of Prof. Petra Feyer - MASCC
Blog
Jan 9, 2025, 16:07
Eric Racine: The Patient Advocacy Voices Podcast is Back for 2025
Blog
Jan 9, 2025, 16:04
Rachit Khandelwal: New insights on treating infant ALL
Science
Jan 9, 2025, 16:02
Sid Yadav: Changing the landscape of VUS in BRCA2
Insight
Jan 9, 2025, 15:58
Dana-Farber Cancer Institute has officially launched the Center for RAS Therapeutics
Science
Jan 9, 2025, 15:52
Moazzam Shahzad: The role of Allo-HCT in therapy-related myeloid neoplasms
Blog
Jan 9, 2025, 15:50
Elvina Almuradova: Dual-HER2 inhibition with trastuzumab + pertuzumab in HER2-positive mCRC
Insight
Jan 9, 2025, 15:48
Kristina Jankovic: 12-year follow-up of the C9741 trial
Blog
Jan 9, 2025, 15:48
Michael Sapienza: Early-onset colorectal cancer incidence rates are rising in 27 of 50 countries/territories worldwide
Blog
Jan 9, 2025, 15:45
Sami Mansfield: Cardiovascular disease is a leading cause of death among cancer survivors, surpassing cancer itself